symbol,statement_type,period_end,line_item,value
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,1077160000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-58080000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,22300000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,3780000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-347810000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,End Cash Position,942250000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,1137510000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,-3780000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-191480000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-725440000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-33420000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-590300000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,3780000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,3780000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-35780000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,-58080000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,-58080000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,22300000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,22300000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-891010000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,99430000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-647900000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-647900000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,-9730000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,-9730000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-332810000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,5270000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-338080000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure Reported,0.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,1424970000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-596740000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-122300000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,-22800000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,133680000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Change In Payable,12060000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-77970000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-177750000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-60800000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,34460000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,9980000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,365560000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Depreciation,365560000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-82250000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-840000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-2170000.0
ADVENZYMES.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,1873640000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,940560000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-6480000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,127030000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,0.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-473130000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,End Cash Position,1137510000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,964200000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,-1510000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,174820000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-592380000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-56070000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-29250000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-567120000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,-567120000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,0.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,0.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,120550000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,127030000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,127030000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-6480000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-6480000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-646490000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,129390000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-304300000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-304300000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,-500000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,-500000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-421580000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,1550000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-423130000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure Reported,-49500000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,1413690000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-492340000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-262530000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-1280000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-31440000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-39410000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-238340000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,7730000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-101520000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,30310000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,105700000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,352420000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,77400000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Depreciation,352420000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-108480000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-820000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,2300000.0
ADVENZYMES.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,1878210000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,1021810000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-3220000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,26220000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,1420000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-381810000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,End Cash Position,964200000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,200000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,2673550000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,126620000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-1836170000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-257980000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,-68000000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-24210000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-125420000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-125420000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,1420000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,1420000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,23000000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,26220000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,26220000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-3220000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-3220000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,0.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-2981810000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,500000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,78700000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-2681740000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,0.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-2681740000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,-760000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,-760000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-378510000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,2540000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-381050000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure Reported,0.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,1403620000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-366390000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-3410000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,22860000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,15460000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Change In Payable,60280000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,7550000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-101340000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-21140000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Stock Based Compensation,0.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,4200000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,350290000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,73040000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Depreciation,277250000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,21980000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-1070000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,7990000.0
ADVENZYMES.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,1403880000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,941150000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-23200000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,6740000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,4340000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-281760000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,End Cash Position,2673550000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,1919190000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,54320000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,700040000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-485000000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,-211250000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-17760000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-118600000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-118600000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,4340000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,4340000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-81380000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-64920000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,-64920000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,0.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-16460000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-23200000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,6740000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-37870000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,12280000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,218600000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,220990000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-2390000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,0.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,0.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-600000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-600000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-268150000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,13010000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-281160000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure Reported,
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,1222910000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-545310000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-273990000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-28300000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,6680000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Change In Payable,27980000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-260950000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-14030000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,7200000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Stock Based Compensation,0.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,-9930000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,349830000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,79980000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Depreciation,269850000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-3250000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-80000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-11500000.0
ADVENZYMES.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,1710580000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,6020000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,39830000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,-79810000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,-111530000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,39830000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,-125360000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,80200000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,-16260000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,-16260000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure Reported,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Stock Based Compensation,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,64120000.0
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Depreciation,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
ADVENZYMES.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
